State Street
SNNA

State Street’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

State Street’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-235,967
Closed -$547K – 3871
2019
Q1 		$547K Buy
235,967
+8,149
+4% +$22.1K ﹤0.01% 3431
2018
Q4 		$529K Sell
227,818
-4,408
-2% -$38.9K ﹤0.01% 3435
2018
Q3 		$3.44M Buy
232,226
+13,628
+6% +$217K ﹤0.01% 3036
2018
Q2 		$3.32M Buy
218,598
+11,572
+6% +$196K ﹤0.01% 3049
2018
Q1 		$3.89M Buy
207,026
+160,767
+348% +$2.81M ﹤0.01% 2914
2017
Q4 		$840K Buy
46,259
+19,952
+76% +$422K ﹤0.01% 3382
2017
Q3 		$586K Buy
+26,307
New +$577K ﹤0.01% 3452

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return